Thursday, March 19, 2026
5:00 PM – 6:00 PM UTC
1:00 PM – 2:00 PM EDT
6:00 PM – 7:00 PM CET
Learning Objectives:
-
Improve understanding of the burden and clinical significance of menopause-related symptoms—including vasomotor symptoms (VMS), sleep disturbances, and weight fluctuations—in women with breast cancer receiving endocrine therapy
-
Review evidence from the OASIS clinical program for non-hormonal management of vasomotor symptoms
-
Provide practical, patient-centered strategies for managing vasomotor symptoms, sleep disturbances, and weight changes when hormone therapy is contraindicated
-
Integrate patient-centered approaches to optimize quality of life and treatment adherence throughout the breast cancer journey
Agenda:
-
Introduction – Prof. Hope Rugo (Chair)
-
Patient Experience: Living With Menopause Symptoms During Breast Cancer Treatment – Dr. Kelly Shanahan
-
Understanding the Burden of Menopause in Breast Cancer Patients – Dr. Maryam Lustberg
-
Evidence Update: OASIS 1–4 & Non-Hormonal Management Options – Dr. Milana Dolezal
-
Practical Management of Sleep Disturbances & Weight Changes – Brittany Bradford, Nurse Practitioner
-
Q & A
Speakers:
Prof. Hope Rugo
(Chair)
Dr. Kelly Shanahan
Dr. Maryam Lustberg
Dr. Milana Dolezal
Brittany Bradford, Nurse Practitioner
This webinar is made possible by an unrestricted educational grant provided by Bayer
